Lawsuit claims Pfizer massaged Neurontin studies

Oct 8 (Reuters) - Drug maker Pfizer Inc (PFE.N) tried to suppress medical studies that reached unfavorable conclusions about the effectiveness of the company's epilepsy drug Neurontin, internal Pfizer documents submitted in a lawsuit against the company showed.

The documents suggest that Pfizer's marketers influenced Neurontin's scientific record to boost sales at least until 2003 by delaying the publication or altering the conclusions of studies that had found no evidence the drug worked for various conditions besides epilepsy.

The documents, including reports by experts who reviewed thousands of company documents for plaintiffs, were submitted to the U.S. District Court in Boston.

Pfizer did not immediately return a call seeking comment. (Reporting by Ajay Kamalakaran in Bangalore; editing by John Stonestreet)